Michael Schrader
Michael Schrader is co-founder and CEO of Vaxess Technologies, an innovative Cambridge-based company revolutionizing vaccine stabilization and delivery through the...
Peter Blume-Jensen
Synapse spoke with XTuit Pharmaceuticals Chief Scientific Officer Peter Blume-Jensen, MD, PhD, about the company's development of novel microenvironment-activated therapeutics...
Christian Bailey
Synapse spoke with Curated Innovation founder Christian Bailey about his entrepreneurship experiences and leading a multidisciplinary innovation lab at LabCentral...
David Lucchino
Synapse spoke with Entrega President and CEO David Lucchino about his journey from founding a biotech IP firm to CEO...
Amy Schulman
The CEO of Lyndra and Arsia Therapeutics and Venture Partner at Polaris Partners spoke with Synapse about translating an invention...
